Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1563-258X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity ; day:8 ; month:2 ; year:2022 ; pages:1-9
Wiener medizinische Wochenschrift ; (8.2.2022), 1-9
- Urheber
-
Hegen, Harald
Berek, Klaus
Deisenhammer, Florian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10354-022-00912-7
- URN
-
urn:nbn:de:101:1-2022051507042366358508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hegen, Harald
- Berek, Klaus
- Deisenhammer, Florian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Cerebrospinal fluid ubiquitin as a biomarker in neurological diseases
Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
Cerebrospinal fluid research
Cerebrospinal fluid rhinorrhea
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Cerebrospinal fluid ubiquitin as a biomarker in neurological diseases
Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
Cerebrospinal fluid research
Cerebrospinal fluid rhinorrhea
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Cerebrospinal fluid ubiquitin as a biomarker in neurological diseases
Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
Cerebrospinal fluid research